Dana-Farber Research Uncovers Approach to Activating the Immune System Against Metastatic Breast Cancer

Cancer spreads, or metastasizes, when tumor cells shed from a primary solid tumor, for example in the breast, and embed in other organs, such as the lung, liver, and brain, and begin to grow.

By
March 4, 2026
3 min

Dana-Farber

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Cancer Immunotherapy
- Breast Cancer Research
- Metastatic Cancer Biology
#2

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Cancer Immunotherapy
- Breast Cancer
- Translational Oncology
#3

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Breast Cancer
- Cancer Immunotherapy
- Metastatic Disease
#4

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Baltimore, MD
Key Differentiators
- Cancer Immunology
- Breast Cancer
- Metastasis Research
#5

University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

San Francisco, CA
Key Differentiators
- Breast Cancer
- Immunotherapy
- Metastatic Cancer Research

Dana-Farber Research Uncovers Approach to Activating the Immune System Against Metastatic Breast Cancer

Top Institutions in Oncology

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

MD Anderson Cancer Center

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

Original Source(s)

Dana-Farber Research Uncovers Approach to Activating the Immune System Against Metastatic Breast Cancer

Related Content

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity